Large-scale testing (Phase 3)Study completedNCT01908816
What this trial is testing
An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
Who this might be right for
Choroidal NeovascularizationMacular EdemaGlaucoma, Neovascular+1 more
Novartis Pharmaceuticals 270